| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $110.8M | +128.9% |
| Cost of Revenue | $60.5M | +110.7% |
| R&D Expense | $121.2M | +108.5% |
| SG&A Expense | $48.2M | +32.6% |
| Operating Income | -$119.1M | -59.3% |
| Interest Expense | $1.7M | +36.6% |
| Pre-tax Income | -$53.8M | +54.7% |
| Income Tax | -$1.0M | -216.5% |
| Net Income | -$43.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $321.6M | +46.8% |
| Accounts Receivable | $26.4M | +91.0% |
| Inventory | $13.3M | +46.0% |
| Current Assets | $373.9M | +50.7% |
| Total Assets | $603.4M | +28.1% |
| Current Liabilities | $64.0M | +89.7% |
| Long-term Debt | $155.7M | +2671.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$76.7M | -37.5% |
| Capital Expenditures | $7.6M | +182.2% |
| Investing Cash Flow | -$16.3M | +80.7% |
| Financing Cash Flow | $192.7M | -43.4% |
| Free Cash Flow | -$84.3M | -44.1% |
| +50.7% |
| EPS (Basic) | -$0.37 | +70.6% |
| EPS (Diluted) | -$0.37 | +70.6% |
| Total Liabilities |
| $289.0M |
| +61.4% |
| Stockholders' Equity | $312.8M | -0.1% |